Pediatric Off-Label Use of Covid-19 Vaccines: Ethical and Legal Considerations
When the U.S. Food and Drug Administration fully approved the Pfizer-BioNTech Covid-19 vaccine for people sixteen and older, questions arose. Parents, pediatricians, and the media wondered whether Covid-19 vaccines could be used off-label—and whether they should be. The American Academy of Pediatric...
Authors: | ; |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Wiley
2021
|
In: |
The Hastings Center report
Year: 2021, Volume: 51, Issue: 6, Pages: 27-32 |
Further subjects: | B
off-label use
B Covid-19 B Vaccination B Equity B Children |
Online Access: |
Volltext (kostenfrei) Volltext (kostenfrei) |